Kyowa Hakko Kirin Co. Ltd, Archimedes Pharma deal

Kyowa’s ProStrakan Group plc subsidiary will acquire Archimedes from life science investor Novo A/S for L230 million ($394.4 million) in cash. Archimedes has technologies for

Read the full 256 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE